Best for
Mobile

GCP Asset Backed Income Limited (GABI) is a leading asset management business based in the UK. GCP Asset Backed Income is listed on the London Stock Exchange (LSE). All prices are listed in pence sterling.
Best for
Mobile
Best for
Low-cost
Best for
All rounder
Best for
Beginners
52-week range | 62.4382p - 104.8204p |
---|---|
50-day moving average | 91.1114p |
200-day moving average | 89.8776p |
Wall St. target price | 109.7p |
PE ratio | 18.6122 |
Dividend yield | 0.06p (7.03%) |
Earnings per share (TTM) | 4.9p |
Other fees may apply. Your capital is at risk.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Valuing GCP Asset Backed Income stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of GCP Asset Backed Income's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
GCP Asset Backed Income's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 19x. In other words, GCP Asset Backed Income shares trade at around 19x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the FTSE 250 at the end of September 2019 (19.71). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Revenue TTM | £28 million |
---|---|
Operating margin TTM | 80.42% |
Gross profit TTM | £32.8 million |
Return on assets TTM | 3% |
Return on equity TTM | 0% |
Profit margin | 77.73% |
Book value | 1.008p |
Market capitalisation | £401.4 million |
TTM: trailing 12 months
We're not expecting GCP Asset Backed Income to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
Over the last 12 months, GCP Asset Backed Income's shares have ranged in value from as little as 62.4382p up to 104.8204p. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while GCP Asset Backed Income's is 0.7905. This would suggest that GCP Asset Backed Income's shares are less volatile than average (for this exchange).
Subscribe to trending stock alerts for a chance to win
Project Finance Investments Limited is an investment firm based in Jersey, Channel Islands.
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.